Following the Strides purchase of the Aspen Australia Generics business finalised on September 1, 2015, Arrow Pharmaceuticals begins operating in the Australian market for the second time. Although the business re-enters the market under new owners and our industry has changed significantly in the fifteen years, the passion and determination for change remains in the DNA of the name and the business. Backed by the global strength of Strides, and working off the strong foundation already built in the business that has been purchased, Arrow Pharmaceuticals will prove to the Australian market that our industry, in particular retail pharmacy, is well and truly viable and integral to the communities they service. Headed by Chairman Dennis Bastas, Arrow Pharmaceuticals brings together a team of industry professionals with incomparable experience across R&D, business development, professional services, sales and marketing.